Addentax Group Corp. (ATXG) vs BioNexus Gene Lab Corp. (BGLC)

A side-by-side comparison of Addentax Group Corp. and BioNexus Gene Lab Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ATXG vs BGLC

growth of $100 · dividends reinvested · last 6y
ATXG -99.7% (-61.5%/yr)BGLC -99.5% (-58.9%/yr)BGLC compounded faster over this window
02k4k6k8k10kStart $10020222023202420252026$0$0
ATXG BGLC

ATXG vs BGLC: by the numbers

  • •ATXG is the larger company ($3M vs $3M market cap).
  • •Both run net losses; ATXG's is the smaller (-21.14% vs -82.36% net margin).
  • •Both shrank revenue over the past five years; ATXG's decline was smaller (-19.15% vs -31.68% CAGR).

Metrics side by side

Valuation

MetricATXGBGLC
P/S ratio0.430.95
P/B ratio0.140.38

Profitability

MetricATXGBGLC
Gross margin12.30%11.64%
Operating margin-23.17%-42.54%
Net margin-21.14%-82.36%
ROE-6.64%-33.11%
ROIC-6.73%-32.71%

Growth (annualized)

MetricATXGBGLC
Revenue CAGR (5Y)-19.15%-31.68%
Total return CAGR (5Y)-68.67%-61.00%

Frequently asked

Which has grown faster, ATXG or BGLC?
Neither grew: over the past five years both shrank revenue, with ATXG's decline the smaller — ATXG at a -19.15% CAGR versus BGLC at -31.68%.
How have ATXG and BGLC total returns compared?
Over the past 5 years, ATXG delivered -68.67% and BGLC delivered -61.00% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.